These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 479381)

  • 21. Pharmacokinetics of cefazolin in patients with renal failure; special reference to hemodialysis.
    Brogard JM; Pinget M; Brandt C; Lavillaureix J
    J Clin Pharmacol; 1977 Apr; 17(4):225-30. PubMed ID: 849996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of cefamandole in patients with normal and impaired renal function.
    Mellin HE; Welling PG; Madsen PO
    Antimicrob Agents Chemother; 1977 Feb; 11(2):262-6. PubMed ID: 848932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of pharmacokinetics.
    Cutler RE
    Rev Infect Dis; 1984; 6 Suppl 4():S803-8. PubMed ID: 6522921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjustment of cephaloridine (Keflodin): dosage according to its pharmacokinetics.
    Brogard JM; Brandt C; Dorner M; Dammron A
    Chemotherapy; 1976; 22(1):1-11. PubMed ID: 1253626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition kinetics of cefamandole during continuous ambulatory peritoneal dialysis.
    Bliss M; Mayersohn M; Arnold T; Logan J; Michael UF; Jones W
    Antimicrob Agents Chemother; 1986 Apr; 29(4):649-53. PubMed ID: 3707113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP
    Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative pharmacokinetics of cefoperazone and cefamandole.
    Srinivasan S; Francke EL; Neu HC
    Antimicrob Agents Chemother; 1981 Feb; 19(2):298-301. PubMed ID: 6214988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
    Barriere SL; Hatheway GJ; Gambertoglio JG; Lin ET; Conte JE
    Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrolysis of cefamandole nafate in dialysis patients.
    Nielsen RL; Wolen R; Luft FC; Ozawa T
    Antimicrob Agents Chemother; 1979 Nov; 16(5):683-5. PubMed ID: 526012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cefamandol: pharmacokinetics with normal and impaired renal function (author's transl)].
    Höffler D; Moecke D; Sassmann M
    Dtsch Med Wochenschr; 1978 Aug; 103(34):1334-8. PubMed ID: 679835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosage adjustments of cefazolin according to the pharmacokinetics of this new cephalosporin.
    Lavillaureix J; Brogard JM; Pinget M; Ledoux F
    Infection; 1975; 3(2):105-14. PubMed ID: 1102452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefsulodin kinetics in renal impairment.
    Gibson TP; Granneman GR; Kallal JE; Sennello LT
    Clin Pharmacol Ther; 1982 May; 31(5):602-8. PubMed ID: 7075110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrolysis of cefamandole nafate to cefamandole in vivo.
    Wold JS; Joost RR; Black HR; Griffith RS
    J Infect Dis; 1978 May; 137 Suppl():S17-S24. PubMed ID: 650001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of ceforanide.
    Ripa S; La Rosa F; Ghezzi A; Prenna M; Pfeffer M
    Antimicrob Agents Chemother; 1982 Feb; 21(2):323-6. PubMed ID: 7073268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of cefamandole in patients with renal failure.
    Meyers BR; Hirschman SZ
    Antimicrob Agents Chemother; 1977 Feb; 11(2):248-50. PubMed ID: 848929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
    J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and safety of cefamandole in newborn infants.
    Agbayani MM; Khan AJ; Kemawikasit P; Rosenfeld W; Salazar D; Kumar K; Glass L; Evans HE
    Antimicrob Agents Chemother; 1979 May; 15(5):674-6. PubMed ID: 525985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic profile of benoxaprofen in subjects with normal and impaired renal function, prediction of multiple-dose kinetics.
    Brogard JM; Comte F; Madon M; Spach MO
    Eur J Rheumatol Inflamm; 1982; 5(2):113-23. PubMed ID: 7084275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceforanide pharmacokinetics in haemodialysis: the effect of ultrafiltration.
    Lanao JM; de Prada CR; Dominguez-Gil A; Tabernero JM; Martín J; Gómez JR
    Biopharm Drug Dispos; 1986; 7(4):335-46. PubMed ID: 3768489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of moxalactam in patients with renal insufficiency.
    Lam M; Manion CV; Czerwinski AW
    Antimicrob Agents Chemother; 1981 Mar; 19(3):461-4. PubMed ID: 6454383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.